Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Orthofix Medical Inc.

OFIXNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Aug 18, 2026Accepted Aug 18, 2026, 5:05 PM EDTFiling CIK 884624Accession 0001794034-26-000005
Share

Structured filing — 4

primary_doc.xml

Open full document ↗

Filing details

Report period
2026-08-14
Issuer
Orthofix Medical Inc.
Issuer CIK
0000884624
Trading symbol
OFIX

Reporting owner 1

Name
Juniper Investment Company, LLC
Reporting owner CIK
0001794034
Relationship
10% owner
Address
555 MADISON AVENUE, 24TH FLOOR, NEW YORK, NY, 10022-3315

Reporting owner 2

Name
Bartholdson John A.
Reporting owner CIK
0001382909
Relationship
10% owner
Address
C/O STONINGTON PARTNERS, INC., 540 MADISON AVENUE, 25TH FLOOR, NEW YORK, NY, 10022

Reporting owner 3

Name
MICHAS ALEXIS P
Reporting owner CIK
0001044005
Relationship
10% owner
Address
77 4TH AVENUE, C/O REVVITY, WALTHAM, MA, 02451-7567

Non-derivative transactions

Non-derivative transactions · 2 reported rows
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnershipNature of ownership
Common Stock, $0.10 par value per share2026-08-14S · Form 419,500A10.3838[F1]64,926IBy: Juniper Multi-Strategy Fund, L.P.[F3]
Common Stock, $0.10 par value per share2026-08-17S · Form 420,000A10.013[F2]84,926IBy: Juniper Multi-Strategy Fund, L.P.[F3]
Table key
S · Form 4
Sale on the market or privately
A
Acquired
I
Indirect

Non-derivative holdings

Non-derivative holdings · 2 reported rows
SecurityAmount ownedOwnershipNature of ownership
Common Stock, $0.10 par value per share935,901IBy: Juniper Targeted Opportunities, L.P.[F4]
Common Stock, $0.10 par value per share3,461,216IBy: Juniper Targeted Opportunity Fund, L.P.[F5]
Table key
I
Indirect

Footnotes

F1
Represents the weighted average per share price with a range from $10.30 and $10.43. The reporting person undertakes to provide details of the trades to the Issuer or the Securities and Exchange Commission upon request.↩ 1
F2
Represents the weighted average per share price with a range from $9.97 and $10.04. The reporting person undertakes to provide details of the trades to the Issuer or the Securities and Exchange Commission upon request.↩ 1
F3
As the investment manager of Juniper Multi-Strategy Fund" (Juniper Multi-Strategy"), Juniper Investment Company may be deemed to beneficially own the securities held by Juniper Multi-Strategy. Juniper Investment Company disclaims beneficial ownership of all interests reported herein except to the extent of its pecuniary interest therein. Messrs. Bartholdson and Michas serve as the managing members of Juniper Investment Company and the general partner of Juniper Multi-Strategy, and as a result, Messrs. Bartholdson and Michas share voting and dispositive power over such shares with Juniper Investment Company. Messrs. Bartholdson and Michas disclaim beneficial ownership of the holdings of Juniper Multi-Strategy reflected herein except to the extent of their pecuniary interest therein.↩ 1↩ 2
F4
As the investment manager of Juniper Targeted Opportunities, LP (Juniper Targeted Opportunities"), Juniper Investment Company may be deemed to beneficially own the securities held by Juniper Targeted Opportunities, Juniper Investment Company disclaims beneficial ownership of all interests reported herein except to the extent of its pecuniary interest therein. Messrs. Bartholdson and Michas serve as the managing members of Juniper Investment Company and the general partner of Juniper Targeted Opportunities, and as a result, Messrs. Bartholdson and Michas share voting and dispositive power over such shares with Juniper Investment Company. Messrs. Bartholdson and Michas disclaim beneficial ownership of the holdings of Juniper Targeted Opportunities reflected herein except to the extent of their pecuniary interest therein.↩ 1
F5
As the investment manager of Juniper Targeted Opportunity Fund, L.P. (Juniper Targeted Opportunity Fund"), Juniper Investment Company may be deemed to beneficially own the securities held by the Juniper Targeted Opportunity Fund, Juniper Investment Company disclaims beneficial ownership of all interests reported herein except to the extent of its pecuniary interest therein. John A. Bartholdson and Alexis P. Michas serve as the managing members of Juniper Investment Company and the general partner of Juniper Targeted Opportunity Fund, and as a result, Messrs. Bartholdson and Michas share voting and dispositive power over such shares with Juniper Investment Company. Messrs. Bartholdson and Michas disclaim beneficial ownership of the holdings of Juniper Targeted Opportunity Fund reflected herein except to the extent of their pecuniary interest therein.↩ 1

Signature 1

Signed
Juniper Investment Company, LLC, By:/s/ John A. Bartholdson
Date
2026-08-18

Signature 2

Signed
/s/ John A. Bartholdson
Date
2026-08-18

Signature 3

Signed
/s/ Alexis P. Michas
Date
2026-08-18

Company context

Orthofix is a global medical technology company dedicated to advancing healing and restoring mobility for patients with complex musculoskeletal conditions. Headquartered in Lewisville, Texas, the Company offers a differentiated portfolio of spinal implants, therapeutic solutions, limb reconstruction systems, biologics and enabling technologies, including the 7D FLASH™ Navigation System. Orthofix’s technology-enabled solutions are designed to support surgeons across the continuum of care and improve outcomes for patients. Learn more at Orthofix.com and follow Orthofix on LinkedIn.

Current securities

Recent company filings

  1. 144 filingSep 1, 2026
  2. SCHEDULE 13G/A - filed by ARMISTICE CAPITAL, LLC regarding Orthofix Medical Inc.Aug 14, 2026
  3. S-8 filingAug 5, 2026
  4. 10-Q filingAug 5, 2026
  5. Results of Operations and Financial Condition · Regulation FD DisclosureAug 5, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.